Jove
Visualize
Contact Us

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors.

Nature cancer·2024
Same author

Quantum Mechanical-Cluster Approach to Solve the Bioisosteric Replacement Problem in Drug Design.

Journal of chemical information and modeling·2023
Same author

Clinical CDK2 Inhibitors: Trends to Selectivity and Efficacy.

Recent patents on anti-cancer drug discovery·2022
Same author

A New Class of Uracil-DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme.

Molecules (Basel, Switzerland)·2021
Same author

Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin.

European journal of medicinal chemistry·2020
Same author

The role of human in the loop: lessons from D3R challenge 4.

Journal of computer-aided molecular design·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 24, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Developing novel approaches to improve binding energy estimation and virtual screening: a PARP case study.

Fedor N Novikov1, Viktor S Stroylov, Oleg V Stroganov

  • 1MolTech Ltd, Moscow, Leninskie gory, Russia.

Journal of Molecular Modeling
|April 17, 2009
PubMed
Summary

Computational chemistry, specifically molecular docking and scoring, effectively screens Poly-(ADP-ribose)-polymerase (PARP) inhibitors. This approach rivals experimental methods for assessing binding and identifying active compounds, aiding anti-cancer drug discovery.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jun 24, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

  • Computational Chemistry
  • Drug Discovery
  • Molecular Biology

Background:

  • Poly-(ADP-ribose)-polymerase (PARP) is a key target in anti-cancer therapy due to its role in DNA repair and cell survival.
  • Developing cost-effective experimental methods for screening PARP inhibitors remains a challenge due to difficulties in quantifying enzyme activity.

Purpose of the Study:

  • To evaluate the efficacy of computational chemistry tools, including molecular docking and scoring, for screening Poly-(ADP-ribose)-polymerase (PARP) inhibitors.
  • To assess the ability of computational methods to accurately predict binding constants and identify active compounds in virtual screening.

Main Methods:

  • Utilized the Lead Finder software for molecular docking and scoring of 142 characterized PARP inhibitors.
  • Correlated calculated binding energies with experimentally measured values, refining scoring function coefficients.
  • Performed virtual screening of a large compound library, incorporating structural filtration based on hydrogen bonding interactions.

Main Results:

  • Achieved good correlation between calculated and experimental binding energies (rmsd of 1.67 kcal mol(-1)), improved to 0.88 kcal mol(-1) after fine-tuning.
  • Successfully reproduced isoform selectivity between PARP1 and PARP2, indicating potential for designing selective inhibitors.
  • Demonstrated significant enrichment of active compounds in virtual screening experiments, enhanced by structural filtration.

Conclusions:

  • Computational chemistry tools, particularly Lead Finder, are effective and comparable to experimental methods for screening PARP inhibitors.
  • The software can accurately predict binding affinities and selectivity, aiding in the design of targeted anti-cancer therapeutics.
  • Virtual screening performance is significantly improved by incorporating structural filtration, such as hydrogen bond detection.